Segui
Fabrizio Bossa
Fabrizio Bossa
Dirigente Medico - Fondazione Casa Sollievo della Sofferenza - IRCCS - San Giovanni Rotondo
Email verificata su operapadrepio.it
Titolo
Citata da
Citata da
Anno
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
MC Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J ...
919*2019
Ulcerative colitis–risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study
MS Silverberg, JH Cho, JD Rioux, DPB McGovern, J Wu, V Annese, ...
Nature genetics 41 (2), 216-220, 2009
5002009
Ulcerative colitis–risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study
MS Silverberg, JH Cho, JD Rioux, DPB McGovern, J Wu, V Annese, ...
Nature genetics 41 (2), 216-220, 2009
4972009
Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease
G Monteleone, MF Neurath, S Ardizzone, A Di Sabatino, MC Fantini, ...
New England Journal of Medicine 372 (12), 1104-1113, 2015
4752015
Advanced age is an independent risk factor for severe infections and mortality in patients given anti–tumor necrosis factor therapy for inflammatory bowel disease
M Cottone, A Kohn, M Daperno, A Armuzzi, L Guidi, R D'Inca, F Bossa, ...
Clinical Gastroenterology and Hepatology 9 (1), 30-35, 2011
3732011
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study
C Bezzio, S Saibeni, A Variola, M Allocca, A Massari, V Gerardi, V Casini, ...
Gut 69 (7), 1213-1217, 2020
3442020
Infliximab reduces endoscopic, but not clinical, recurrence of Crohn’s disease after ileocolonic resection
M Regueiro, BG Feagan, B Zou, J Johanns, MA Blank, M Chevrier, ...
Gastroenterology 150 (7), 1568-1578, 2016
3132016
Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis
V Annese, MR Valvano, O Palmieri, A Latiano, F Bossa, A Andriulli
World journal of gastroenterology: WJG 12 (23), 3636, 2006
1802006
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between …
BD Juran, GM Hirschfield, P Invernizzi, EJ Atkinson, Y Li, G Xie, R Kosoy, ...
Human molecular genetics 21 (23), 5209-5221, 2012
1712012
Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection
S Ben-Horin, M Margalit, P Bossuyt, J Maul, Y Shapira, D Bojic, ...
Clinical Gastroenterology and Hepatology 7 (9), 981-987, 2009
1532009
The PROSIT-BIO cohort: a prospective observational study of patients with inflammatory bowel disease treated with infliximab biosimilar
G Fiorino, N Manetti, A Armuzzi, A Orlando, A Variola, S Bonovas, ...
Inflammatory bowel diseases 23 (2), 233-243, 2017
1482017
Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
A Bourrier, F Carrat, JF Colombel, AM Bouvier, V Abitbol, P Marteau, ...
Alimentary pharmacology & therapeutics 43 (2), 252-261, 2016
1362016
Methotrexate is not superior to placebo for inducing steroid-free remission, but induces steroid-free clinical remission in a larger proportion of patients with ulcerative colitis
F Carbonnel, JF Colombel, J Filippi, KH Katsanos, L Peyrin-Biroulet, ...
Gastroenterology 150 (2), 380-388. e4, 2016
1342016
Randomised controlled trial of mesalazine in IBS
G Barbara, C Cremon, V Annese, G Basilisco, F Bazzoli, M Bellini, ...
Gut 65 (1), 82-90, 2016
1272016
Continuous infusion versus bolus administration of steroids in severe attacks of ulcerative colitis: a randomized, double-blind trial
F Bossa, S Fiorella, N Caruso, L Accadia, G Napolitano, MR Valvano, ...
Official journal of the American College of Gastroenterology| ACG 102 (3 …, 2007
1142007
Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease
A Latiano, O Palmieri, L Pastorelli, M Vecchi, TT Pizarro, F Bossa, G Merla, ...
PloS one 8 (4), e62144, 2013
1132013
Polymorphisms of tumor necrosis factor-α but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease
S Cucchiara, A Latiano, O Palmieri, RB Canani, R D'Incà, G Guariso, ...
Journal of pediatric gastroenterology and nutrition 44 (2), 171-179, 2007
1052007
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study
A Orlando, E Colombo, A Kohn, L Biancone, F Rizzello, A Viscido, ...
Digestive and liver disease 37 (8), 577-583, 2005
1012005
Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD)
M Daperno, M Comberlato, F Bossa, L Biancone, AG Bonanomi, ...
Digestive and Liver Disease 46 (11), 969-973, 2014
992014
Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection
S Ben-Horin, M Margalit, P Bossuyt, J Maul, Y Shapira, D Bojic, ...
Journal of Crohn's and Colitis 4 (2), 194-198, 2010
982010
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20